Lisata Therapeutics | 8-K: Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Lisata Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Lisata Therapeutics | DEF 14A: Definitive information statements
Lisata Therapeutics | DEFA14A: Others
Lisata Therapeutics | 8-K: Current report
Lisata Therapeutics | 8-K: Current report
Lisata Therapeutics | 8-K: Lisata Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Lisata Therapeutics | 8-K: Lisata Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
Lisata Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Lisata Therapeutics | 8-K: Current report
Lisata Therapeutics | 8-K: Current report
Lisata Therapeutics | 8-K: Lisata Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
Lisata Therapeutics | DEFA14A: Others
Lisata Therapeutics | DEF 14A: Definitive proxy statements
Lisata Therapeutics | 8-K: Current report
Lisata Therapeutics | 8-K: Lisata Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Lisata Therapeutics | 8-K: Current report
Lisata Therapeutics | 8-K: Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Lisata Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Lisata Therapeutics | 8-K/A: Current report (Amendment)
No Data